Primary osteosarcoma of the urinary bladder treated with external radiotherapy in a patient with a history of transitional cell carcinoma: a case report

by Kappes George, Skopelitou Antigoni, Papandreou Christos, Daouaher Housam
Published 2010-02-01

The ubiquitin-proteasome system in glioma cell cycle control

by Vlachostergios Panagiotis J, Voutsadakis Ioannis A, Papandreou Christos N
Published 2012-07-01

Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells

by Patrikidou Anna, Vlachostergios Panagiotis J, Voutsadakis Ioannis A, Hatzidaki Eleana, Valeri Rosalia-Maria, Destouni Chariklia, Apostolou Effie, Papandreou Christos N
Published 2012-06-01

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells

by Apostolou Effie, Destouni Chariklia, Valeri Rosalia-Maria, Hatzidaki Eleana, Voutsadakis Ioannis A, Vlachostergios Panagiotis J, Patrikidou Anna, Daliani Danai, Papandreou Christos N
Published 2011-05-01

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma

by Papazisis Konstantinos T, Kontovinis Lukas F, Papandreou Christos N, Kouvatseas George, Lafaras Christos, Antonakis Evangelos, Christopoulou Maria, Andreadis Charalambos, Mouratidou Despoina, Kortsaris Alexandros H
Published 2010-09-01

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

by Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A
Published 2010-02-01

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with coll...

by Pectasides Dimitrios, Papaxoinis George, Kalogeras Konstantine T, Eleftheraki Anastasia G, Xanthakis Ioannis, Makatsoris Thomas, Samantas Epaminondas, Varthalitis Ioannis, Papakostas Pavlos, Nikitas Nikitas, Papandreou Christos N, Pentheroudakis George, Timotheadou Eleni, Koutras Angelos, Sgouros Joseph, Bafaloukos Dimitrios, Klouvas George, Economopoulos Theofanis, Syrigos Konstantinos N, Fountzilas George
Published 2012-06-01